Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	3035.89	1276.89	-40.72
Graham Fair Price	12.03	4723.55	4216.32
PEG	1056.32	-0.06	< 0.005
Price/Book	-17.00	0.74	0.89
Price/Cash Flow	inf	0.00	99.62
Prices/Earnings	39.83	-2.01	-3.34
Price/Sales	-29.07	5.40	7.62
Price/FCF	inf	0.00	99.62
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	63.52	< 0.005	< 0.005
ROA	-33.65	< 0.005	< 0.005
ROE	-0.07	-0.09	-37.96
ROIC	< 0.005	< 0.005	252.76
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.06	0.40	-86.27
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.97	0.83	-14.52
EPS QOQ	-6.07	-0.32	94.80
FCF QOQ	< 0.005	0.00	inf
Revenue QOQ	0.29	0.12	-59.59
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.73	0.73	-0.25
Quick Ratio	0.39	-3.36	754.39
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	3450.15	3290.79	-4.62
Cash	13160.05	-13635.06	3.61
Capex	0.00	n.A.	n.A.
Free Cash Flow	30.75	n.A.	n.A.
Revenue	402.05	448.76	11.62
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.48	3.95	727.62
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-214.51	1152.65	437.35
Naive Interpretation	Member

06 - Financial Health · Bad

Rating